Kaushik Kantilal Shah
About Kaushik Kantilal Shah
Data last updated:
Kaushik Kantilal Shah is a Managing Director at Sushen Medicamentos Private Limited (since 2003) and Designated Partner at Quadbiogen Llp (since 2021). The companies operate in Healthcare, Pharma and Professional Services. The 2 current companies with reported revenue have a combined latest revenue of ₹30.61 Cr; the largest is Sushen Medicamentos Private Limited at ₹30.42 Cr (FY 2025). Earlier, Kaushik Kantilal Shah was a Director at Dmk Ventures Private Limited (2009–2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sushen Medicamentos Private Limited U24231GJ2001PTC040113 | Managing Director | 01 Jul 2003 | 2001 | ₹30.42 Cr (FY 2025) | Active |
 Quadbiogen Llp AAV-5846 | Designated Partner | 01 May 2021 | 2021 | ₹19 Lakh (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Dmk Ventures Private Limited U20237GJ2009PTC058399 | Director | 19 Oct 2009 | 2009 | ₹17,000 (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kaushik Kantilal Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aman Kulabkar | 06998800 | Sushen Medicamentos Private Limited | Director |
| Venkatram Bakthavatchalam | 06856800 | Quadbiogen Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kaushik Kantilal Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kaushik Kantilal Shah
Kaushik Kantilal Shah currently holds 2 directorships: Sushen Medicamentos Private Limited (Managing Director, since 01 Jul 2003, revenue ₹30.42 Cr (FY 2025)); Quadbiogen Llp (Designated Partner, since 01 May 2021, revenue ₹19 Lakh (FY 2023)).
Kaushik Kantilal Shah was first appointed on 01 Jul 2003 as Managing Director at Sushen Medicamentos Private Limited. The most recent appointment on record is 01 May 2021 at Quadbiogen Llp.
The 2 current companies of Kaushik Kantilal Shah that report revenue have a combined latest revenue of ₹30.61 Cr: Sushen Medicamentos Private Limited ₹30.42 Cr (FY 2025); Quadbiogen Llp ₹19 Lakh (FY 2023).
Kaushik Kantilal Shah held 1 earlier board appointment: Dmk Ventures Private Limited (Director, 19 Oct 2009 to 21 Dec 2018).
The current boards of Kaushik Kantilal Shah's companies include Aman Kulabkar (Sushen Medicamentos Private Limited), Venkatram Bakthavatchalam (Quadbiogen Llp).